Buspirone hydrochloride NDC 11788-060

NDC codes

FDA NDC Directory

Product NDC (as listed)11788-060Labeler and product segments. Claims need a package NDC.

Product NDC at billing width11788-0060Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
11788-060-01	11788006001	100 TABLET in 1 BOTTLE (11788-060-01)Marketed from Sep 26, 2025
11788-060-03	11788006003	180 TABLET in 1 BOTTLE (11788-060-03)Marketed from Aug 1, 2026
11788-060-05	11788006005	500 TABLET in 1 BOTTLE (11788-060-05)Marketed from Sep 26, 2025
11788-060-60	11788006060	60 TABLET in 1 BOTTLE (11788-060-60)Marketed from Aug 1, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Buspirone hydrochloride
Generic name (nonproprietary): buspirone hydrochloride
Active ingredients: Buspirone hydrochloride — 15 mg/1
Dosage form: Tablet
Route: Oral
Labeler: AiPing Pharmaceutical, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 202087
Marketing start: Sep 26, 2025
Listing expires: Dec 31, 2027
Identifiers: Product ID 11788-060_2a9a38df-c46f-437c-ac13-f5256941b1e1SPL ID 2a9a38df-c46f-437c-ac13-f5256941b1e1SPL set ID 55810b17-4796-49d0-90e4-8e075d62eda4RxCUI 866018, 866083, 866090, 866094, 866111UNII 207LT9J9OC

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N411788006001 followed by a unit qualifier and the quantity

Package 11788-0060-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 29, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Buspirone hydrochloride tablets are indicated for the management of anxiety disorders or the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. The efficacy of buspirone hydrochloride tablets has been demonstrated in controlled clinical trials of outpatients whose diagnosis roughly corresponds to Generalized Anxiety Disorder (GAD). Many of the patients enrolled in these studies also had coexisting depressive symptoms and buspirone hydrochloride tablets relieved anxiety in the presence of these coexisting depressive symptoms. The patients evaluated in these st…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)